Catalent Inc
Company Profile
Business description
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Contact
14 Schoolhouse Road
SomersetNJ08873
USAT: +1 732 537-6200
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2025
Employees
16,900
Catalent Inc News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,579.10 | 50.10 | -0.58% |
CAC 40 | 7,265.23 | 35.59 | 0.49% |
DAX 40 | 19,163.35 | 103.04 | 0.54% |
Dow JONES (US) | 43,268.94 | 120.66 | -0.28% |
FTSE 100 | 8,119.55 | 20.53 | 0.25% |
HKSE | 19,705.01 | 41.34 | 0.21% |
NASDAQ | 18,987.47 | 195.66 | 1.04% |
Nikkei 225 | 38,352.34 | 62.09 | -0.16% |
NZX 50 Index | 12,737.06 | 79.26 | -0.62% |
S&P 500 | 5,916.98 | 23.36 | 0.40% |
S&P/ASX 200 | 8,326.30 | 47.70 | -0.57% |
SSE Composite Index | 3,367.99 | 21.98 | 0.66% |